Louisa Aldrich-Blake

From WikiMD's WELLNESSPEDIA

Louisa Aldrich-Blake (1865–1925) was a pioneering British surgeon and the first woman to obtain a Master of Surgery degree in Britain. She is best known for her work in developing new surgical techniques for treating cancers of the cervix and rectum.

Early Life and Education[edit]

Louisa Aldrich-Blake was born on 15 August 1865 in Chingford, Essex. She was the daughter of a clergyman, Reverend Frederick Aldrich-Blake. She attended the Cheltenham Ladies' College and later studied at the London School of Medicine for Women, where she graduated with a Bachelor of Medicine degree in 1893.

Career[edit]

In 1894, Aldrich-Blake became the first woman in Britain to receive a Master of Surgery degree. She was appointed assistant surgeon at the New Hospital for Women and the London School of Medicine for Women, where she later became a senior surgeon and dean. Aldrich-Blake was known for her innovative surgical techniques, particularly in the treatment of cancers of the cervix and rectum. She also played a significant role in the development of radium as a treatment for cancer.

Legacy[edit]

Aldrich-Blake's contributions to medicine have been widely recognized. In 1925, the year of her death, the Royal Free Hospital named a ward in her honor. In 1950, a blue plaque was unveiled at her former residence in Bloomsbury, London. In 2019, Google commemorated her with a Google Doodle on what would have been her 154th birthday.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.